Wolverine Trading’s BioLife Solutions BLFS Stock Holding History

Wolverine Trading’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,061	Closed	-$200K	–	5843
2020 Q4	$207K	Buy	+5,061	New	+$173K	﹤0.01%	4187

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Wolverine Trading's BLFS Position: Q1 2021 in Review

Wolverine Trading sold out of BioLife Solutions (BLFS) in Q1 2021, closing a stake of 5,061 shares — an estimated $200K sold.

Wolverine Trading first reported a position in BLFS in Q4 2020 and held it in 1 quarter. The position peaked at $207K in Q4 2020. 132 funds tracked by Wall St. Rank hold BLFS as of Q1 2021.

Wolverine Trading reported no remaining BioLife Solutions position as of Q1 2021 after selling out during the quarter.
Wolverine Trading sold 5,061 BioLife Solutions shares in Q1 2021, an estimated $200K.
Wolverine Trading first reported a position in BioLife Solutions in Q4 2020 and held it in 1 quarter.
Wolverine Trading's BioLife Solutions position peaked at $207K in Q4 2020.
132 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2021.

Based on Wolverine Trading's 13F filing for Q1 2021, filed 14 May 2021.